Nyxoah Announces First Patient Implanted in BREATHE, the U.S. Post-Approval Study of the Genio® System

Go back to Nyxoah Announces First Patient Implanted in BREATHE, the U.S. Post-Approval Study of the Genio® System
(NASDAQ: NYXH) Delayed: 0.83 -0.06 (6.74%)
Previous Close $0.89    52 Week High $ 
Open $0.85    52 Week Low $ 
Day High $0.86    P/E N/A 
Day Low $0.81    EPS $ 
Volume 517,185